Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment

被引：46
|
作者：
Terao, Toshiki [1 ,2 ]
Minami, Yosuke [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan
[2] Kameda Med Ctr, Dept Internal Med, Div Hematol Oncol, Kamogawa 2968602, Japan
来源：
CELLS | 2019年 / 8卷 / 04期
关键词：
Hedgehog pathway; acute myeloid leukemia; AML; leukemic stem cell; glioma; Smoothened; glasdegib; sonidegib; STEM-CELLS; MYELODYSPLASTIC SYNDROME; GLASDEGIB PF-04449913; CLINICAL-IMPLICATIONS; PHASE IB; GLI; INHIBITOR; MUTATIONS; ACTIVATION; THERAPY;
D O I：
10.3390/cells8040312
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are important for the tumor cells' cycle or therapeutic resistance of AML cells. In this article, we will review the current trends in Hh pathway inhibitors for treating AML.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
    Raoul Tibes
    Aref Al-Kali
    Gavin R Oliver
    Devora H Delman
    Nanna Hansen
    Keerthi Bhagavatula
    Jayaram Mohan
    Fariborz Rakhshan
    Thomas Wood
    James M. Foran
    Ruben A. Mesa
    James M. Bogenberger
    Journal of Hematology & Oncology, 8
  • [22] The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
    Tibes, Raoul
    Al-Kali, Aref
    Oliver, Gavin R.
    Delman, Devora H.
    Hansen, Nanna
    Bhagavatula, Keerthi
    Mohan, Jayaram
    Rakhshan, Fariborz
    Wood, Thomas
    Foran, James M.
    Mesa, Ruben A.
    Bogenberger, James M.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [23] Targeting neurolysin in acute myeloid leukemia
    Mirali, Sara
    Schimmer, Aaron D.
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (04)
  • [24] Targeting the Microenvironment in Acute Myeloid Leukemia
    Rashidi, Armin
    Uy, Geoffrey L.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2015, 10 (02) : 126 - 131
  • [25] Molecular targeting in acute myeloid leukemia
    Seah H. Lim
    Patrycja M. Dubielecka
    Vikram M. Raghunathan
    Journal of Translational Medicine, 15
  • [26] Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia
    Huang, Xiaomeng
    Schwind, Sebastian
    Santhanam, Ramasamy
    Eisfeld, Ann-Kathrin
    Chiang, Chi-ling
    Lankenau, Malori
    Yu, Bo
    Hoellerbauer, Pia
    Jin, Yan
    Tarighat, Somayeh S.
    Khalife, Jihane
    Walker, Alison
    Perrotti, Danilo
    Bloomfield, Clara D.
    Wang, Hongyan
    Lee, Robert J.
    Lee, Ly James
    Marcucci, Guido
    ONCOTARGET, 2016, 7 (37) : 59273 - 59286
  • [27] RNA Targeting in Acute Myeloid Leukemia
    Messikommer, Alessandra
    Seipel, Katja
    Byrne, Stephen
    Valk, Peter J. M.
    Pabst, Thomas
    Luedtke, Nathan W.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (06) : 1225 - 1232
  • [28] Targeting the Microenvironment in Acute Myeloid Leukemia
    Armin Rashidi
    Geoffrey L. Uy
    Current Hematologic Malignancy Reports, 2015, 10 : 126 - 131
  • [29] Molecular targeting in acute myeloid leukemia
    Lim, Seah H.
    Dubielecka, Patrycja M.
    Raghunathan, Vikram M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [30] Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase?
    Khan, Alesia A.
    Harrison, Claire N.
    McLornan, Donal P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (03) : 323 - 335
12345